ACP

Acuta Capital Partners Portfolio holdings

AUM $96.8M
1-Year Est. Return 275.72%
This Quarter Est. Return
1 Year Est. Return
+275.72%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$96.8M
AUM Growth
+$25.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
36
New
Increased
Reduced
Closed

Top Buys

1
+$4.53M
2
+$2.94M
3
+$2.21M
4
KRYS icon
Krystal Biotech
KRYS
+$1.87M
5
OCUL icon
Ocular Therapeutix
OCUL
+$1.76M

Top Sells

1
+$5.31M
2
+$3.64M
3
+$2.7M
4
ASND icon
Ascendis Pharma
ASND
+$2.54M
5
RVMD icon
Revolution Medicines
RVMD
+$2.21M

Sector Composition

1 Healthcare 99.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCUL icon
1
Ocular Therapeutix
OCUL
$2.36B
$13.6M 14.08%
1,165,206
+150,266
CDTX
2
DELISTED
Cidara Therapeutics
CDTX
$13.6M 14.01%
141,529
-38,040
TRML
3
DELISTED
Tourmaline Bio
TRML
$12.8M 13.27%
268,451
-15,231
WHWK
4
Whitehawk Therapeutics
WHWK
$137M
$6.48M 6.7%
3,410,402
INSM icon
5
Insmed
INSM
$34.9B
$5.56M 5.74%
38,592
+1,522
DRUG
6
Bright Minds Biosciences
DRUG
$878M
$5.15M 5.32%
84,875
+36,401
ARGX icon
7
argenx
ARGX
$49.5B
$4.7M 4.86%
6,379
-323
AMLX icon
8
Amylyx Pharmaceuticals
AMLX
$1.55B
$4.53M 4.68%
+333,258
TERN icon
9
Terns Pharmaceuticals
TERN
$4.04B
$3.78M 3.9%
502,797
+38,933
JAZZ icon
10
Jazz Pharmaceuticals
JAZZ
$10.4B
$3.31M 3.42%
25,114
-1,169
CMPX icon
11
Compass Therapeutics
CMPX
$1.07B
$2.94M 3.04%
+840,090
PRAX icon
12
Praxis Precision Medicines
PRAX
$8.28B
$2.64M 2.72%
49,751
-24,336
SRZN icon
13
Surrozen
SRZN
$171M
$2.3M 2.38%
178,415
+8,415
ASND icon
14
Ascendis Pharma
ASND
$13.3B
$1.95M 2.01%
9,792
-12,784
KRYS icon
15
Krystal Biotech
KRYS
$8.46B
$1.87M 1.93%
+10,573
OCS icon
16
Oculis Holding
OCS
$1.37B
$1.79M 1.85%
101,777
-4,941
TSHA icon
17
Taysha Gene Therapies
TSHA
$1.38B
$1.49M 1.54%
454,827
-30,842
COGT icon
18
Cogent Biosciences
COGT
$5.8B
$1.48M 1.53%
+102,907
ZYME icon
19
Zymeworks
ZYME
$1.86B
$1.37M 1.41%
80,143
-3,512
VSTM icon
20
Verastem
VSTM
$511M
$1.27M 1.31%
143,446
-6,968
DNTH icon
21
Dianthus Therapeutics
DNTH
$1.98B
$984K 1.02%
+25,000
UTHR icon
22
United Therapeutics
UTHR
$20.5B
$963K 0.99%
+2,296
INBX icon
23
Inhibrx
INBX
$1.1B
$552K 0.57%
+16,377
FULC icon
24
Fulcrum Therapeutics
FULC
$683M
$526K 0.54%
57,141
-2,509
LBRX
25
LB Pharmaceuticals
LBRX
$490M
$474K 0.49%
+30,000
1
2